35 ALIPOGENE TIPARVOVEC GENE THERAPY SIGNIFICANTLY REDUCES...

Atherosclerosis Supplements 2011 / 06 Vol. 12; Iss. 1

35 ALIPOGENE TIPARVOVEC GENE THERAPY SIGNIFICANTLY REDUCES THE RISK OF PANCREATITIS IN LIPOPROTEIN LIPASE DEFICIENT PATIENTS

Greentree, S., Méthot, J., Déry, S., Tremblay, K., de Wal, J., van den Bulk, N., Ruiterkamp, G., Freidig, A., Brisson, D., Gaudet, D.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
12
Language:
english
Journal:
Atherosclerosis Supplements
DOI:
10.1016/s1567-5688(11)70036-8
Date:
June, 2011
File:
PDF, 39 KB
english, 2011
Conversion to is in progress
Conversion to is failed